유럽 연구소는 2028년까지 테스트 시장 예측을 개발했습니다. 유형(임상 생화학, 중환자 치료, 혈액학, 미생물학, 분자 진단, 면역학 및 기타 테스트 유형) 및 애플리케이션(학술 기관, 임상 연구 기관, 병원)별 코로나19 영향 및 지역 분석 실험실, 전문 진단 센터 및 기타)

TIPRE00025752 | Pages: 120 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

시장 소개

실험실 개발 테스트(LDT)는 체외 진단 테스트의 일종으로 다음과 같은 분야에서 설계되고 사용됩니다. 하나의 실험실. 이러한 테스트는 인체 해부학에서 받은 표본에서 단백질, 포도당이나 콜레스테롤과 같은 화학적 화합물, DNA와 같은 광범위한 분석 물질을 추정하거나 구별하는 데 활용될 수 있습니다. 실험실과 진료소에서 정확하고 오류 없는 분석을 제공하기 위한 자동화된 체외 진단(IVD) 방법의 확장이 이러한 증가를 촉진할 것으로 예상됩니다.

 

시장 개요 및 역학

유럽 실험실 개발 테스트 시장은 89억 8,878만 달러에 이를 것으로 예상됩니다. 2021년에는 56억 6,443만 달러에서 2028년까지; 2021년부터 2028년까지 CAGR 6.8%로 성장할 것으로 예상됩니다. 암 및 유전 질환 발병률 증가와 유럽 전역의 제품 출시 증가는 실험실 개발 테스트 시장을 촉진하는 요인입니다. 그러나 변화하는 규제 환경은 실험실 개발 테스트 시장의 성장을 방해하고 있습니다.

LDT는 실험실 내에서 개발 및 사용되며 다른 실험실이나 의료 시설에 배포되거나 판매되지 않습니다. 이러한 테스트는 상용 테스트를 이용할 수 없다는 문제를 극복하기 위해 설계되었습니다. 많은 LDT는 희귀질환을 위해 개발된 유전자 검사입니다. 따라서 새로운 LDT의 개발 및 도입 빈도가 높습니다. 2020년 11월 Aditx Therapeutics, Inc는 면역 모니터링을 위한 AditxtScore 실험실 운영에 대한 CLIA 인증을 획득하여 코로나19 진단을 위한 AditxtScore 테스트를 시작할 수 있었습니다. SARS-CoV-2 변종의 출현이 증가함에 따라 전체 바이러스 게놈에서 돌연변이를 식별, 추적 및 추적해야 할 필요성이 강조되었습니다. 2021년 1월 Eurofins는 SARS-CoV-2의 새로운 변종을 탐지하고 모니터링하기 위한 NovaType 테스트를 시작했습니다. 이 RT-PCR 분석은 B.1.1.7 및 B.1.351 변종을 짧은 시간에 식별하는 데 대해 임상적으로 검증되었습니다. NovaType은 이미 독일에서 LDT로 사용 가능하며 전 세계 50개 이상의 Eurofins 실험실에서 코로나19 환자 테스트를 위해 제공될 예정입니다. 또한 맞춤 의학에 대한 수요 증가는 유럽 실험실 개발 테스트 시장에서 활동하는 플레이어들에게 상당한 성장 기회를 제공하고 있습니다.

유럽 전역의 국가에서 코로나19가 다시 확산되고 있습니다. 전염병을 성공적으로 완화한 후의 사례입니다. 많은 국가에서 2020년의 첫 번째 물결보다 매일 더 많은 사례가 보고되고 있습니다. 많은 국가의 정부는 테스트 용량을 확대하기 위해 노력하고 있으며, 이는 실험실 개발 테스트 시장을 더욱 주도하고 있습니다. 많은 시장 참가자들이 증가하는 수요를 충족하기 위해 제품을 출시했습니다. 예를 들어, 2020년 8월 Eurofins Technologies(룩셈부르크)는 COVID-19에 노출된 환자의 ELISA를 통한 혈청학 기반 항체 검출을 위한 다양한 테스트 키트를 출시했습니다. 이 테스트는 코로나19에 대한 지역별 요구 사항을 충족하도록 설계되었습니다. Viracor Eurofins는 SARS-CoV-2 실험실 개발 테스트에 대해 식품의약국(FDA) 및 긴급 사용 승인(EUA)을 받았습니다. 다른 Eurofins 실험실에서는 현지 규제 의무를 충족하고 전 세계적으로 시약 공급망 문제를 완화하기 위해 대체 RT-PCR 옵션을 개발했습니다. 그러나 기타 비긴급 검사에서는 봉쇄 조치와 의료 기관의 과중한 부담으로 인해 감소세가 나타났습니다.

 

< span>주요 시장 부문

유럽의 실험실 개발 테스트 시장은 유형별로 임상 생화학, 중환자 치료, 혈액학, 미생물학, 분자 진단, 면역학으로 분류됩니다. , 기타 테스트 유형. 혈액학 부문은 응고 및 지혈, 헤모글로빈 테스트, 혈구수 테스트 등으로 세분화되었습니다. 2021년에는 분자 진단 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 그러나 혈액학 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

유럽 연구소에서 개발한 테스트 시장은 응용 분야별로 학술 기관, 임상 연구 기관, 병원 실험실, 전문 진단 센터 등으로 분류됩니다. 병원 연구실 부문은 2021년에 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 그러나 전문 진단 센터 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

 

주요 출처 및 회사 목록

몇 가지 유럽 실험실 개발 테스트 시장 보고서를 준비하는 동안 참조된 1차 및 2차 소스는 독일 진단 산업 협회(VDGH), Deutsche Akkreditierungsstelle GmbH(DAkkS) 및 스페인 심장 재단(FEC)입니다.

< p> 

보고서를 구매하는 이유

  • 향후 유럽 실험실 개발 테스트 시장에 대한 상세한 동향 분석을 바탕으로 향후 투자 영역을 결정합니다.
  • 최고 지출 국가 및 국가에서 다양한 중독 치료제 부문에 대한 수요를 촉진하는 기본 요인에 대한 심층적인 이해를 얻으세요. 각각이 제공하는 기회를 파악하세요.
  • 수요 동인, 업계 동향, 최신 기술 개발 등의 측면에서 시장에 대한 지식을 강화하세요.
  • 유럽 딜티아젬 시장을 주도하는 주요 채널을 파악하고 미래 기회에 대한 명확한 그림을 제공합니다. 분석에 도움이 되어 결과적으로 수익이 확대됩니다.
  • 해당 지역 내 여러 국가에서 진행 중인 프로그램에 집중하여 리소스를 채널화하세요. < span>유럽 실험실 개발 테스트 시장.

 

< span>유럽 실험실에서 개발한 테스트 시장 세분화

유형별

  • < span>임상 생화학
  • 중환자 치료
  • 혈액학
    • 응고 및 지혈,
    • 헤모글로빈 검사
    • 혈구수 검사
    • 기타
  • 면역학
  • 미생물학
  • 분자 진단
  • 기타 테스트 유형

작성자 애플리케이션

  • 학술 기관
  • 임상 연구 기관
  • 병원 실험실
  • 전문 분야 진단 센터
  • 기타

국가별

  • 이탈리아
  • 프랑스
  • 독일
  • 스페인
  • 영국
  • 유럽 나머지 지역

회사 프로필

  • Quest Diagnostics 통합
  • F.HOFFMANN-LA ROCHE LTD
  • QIAGEN
  • Illumina, Inc.
  • Eurofins Scientific
  • Guardant Health
 

TABLE OF CONTENTS

1.             Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Laboratory Developed Test Market – By Type

1.3.2        Europe Laboratory Developed Test Market – By Application

1.3.3        Europe Laboratory Developed Test Market – By Country

2.             Laboratory Developed Test Market – Key Takeaways

3.             Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.             Laboratory Developed Test Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Europe– PEST Analysis

4.3        Experts Opinion

5.             Laboratory Developed Test Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Increasing Incidence of Cancer and Genetic Disorders

5.1.2        Large Number of Product Launches

5.2        Market Restraints

5.2.1        Changing Regulatory Landscape

5.3        Market Opportunities

5.3.1        Continuous Research on Personalized Medicine

5.4        Future Trends

5.4.1        Automation of Laboratory Processes

5.5        Impact Analysis

6.             Laboratory Developed Test Market –Europe Analysis

6.1        Europe Laboratory Developed Test Market Revenue Forecast and Analysis

7.             Laboratory Developed Test Market Analysis – By Type

7.1        Overview

7.2        Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

7.3        Clinical Biochemistry

7.3.1        Overview

7.3.2        Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4        Haematology

7.4.1        Overview

7.4.2        Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Coagulation and Hemostasis

7.4.3.1       Overview

7.4.3.2       Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Hemoglobin Testing

7.4.4.1       Overview

7.4.4.2       Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Blood Count Testing

7.4.5.1       Overview

7.4.5.2       Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6        Others

7.4.6.1       Overview

7.4.6.2       Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.5        Immunology

7.5.1        Overview

7.5.2        Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.6        Critical Care

7.6.1        Overview

7.6.2        Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.7        Microbiology

7.7.1        Overview

7.7.2        Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.8        Molecular Diagnostics

7.8.1        Overview

7.8.2        Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.9        Other Test Types

7.9.1        Overview

7.9.2        Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.             Laboratory Developed Test Market Analysis – By Application

8.1        Overview

8.2        Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

8.3        Academic Institutes

8.3.1        Overview

8.3.2        Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.4        Clinical Research organizations

8.4.1        Overview

8.4.2        Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.5        Hospital laboratory

8.5.1        Overview

8.5.2        Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.6        Specialty Diagnostic Centers

8.6.1        Overview

8.6.2        Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.7        Others

8.7.1        Overview

8.7.2        Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

9.             Laboratory Developed Test Market – Europe Analysis

9.1        Europe: Laboratory Developed Test Market

9.1.1        Overview

9.1.3        Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

9.1.3.1       Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1       Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2       Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.1.2.1           Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.1.3       Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.2       France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1       France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2       France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.2.2.1           France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.2.3       France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.3       UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1       UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2       UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.3.2.1           UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.3.3       UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.4       Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1       Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2       Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.4.2.1           Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.4.3       Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.5       Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1       Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2       Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.5.2.1           Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.5.3       Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.6       Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1       Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2       Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.6.2.1           Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.6.3       Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

10.          Impact Of COVID-19 Pandemic on Laboratory Developed Test Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.          Laboratory Developed Test Market–Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1      Overview

11.3      Organic Growth Strategies

11.3.1      Overview

12.          Company Profiles

12.1      Quest Diagnostics Incorporated

12.1.1      Key Facts

12.1.2      Business Description

12.1.3      Products and Services

12.1.4      Financial Overview

12.1.5      SWOT Analysis

12.1.6      Key Developments

12.2      F.HOFFMANN-LA ROCHE LTD.

12.2.1      Key Facts

12.2.2      Business Description

12.2.3      Products and Services

12.2.4      Financial Overview

12.2.5      SWOT Analysis

12.2.6      Key Developments

12.3      QIAGEN

12.3.1      Key Facts

12.3.2      Business Description

12.3.3      Products and Services

12.3.4      Financial Overview

12.3.5      SWOT Analysis

12.3.6      Key Developments

12.4      Illumina, Inc.

12.4.1      Key Facts

12.4.2      Business Description

12.4.3      Products and Services

12.4.4      Financial Overview

12.4.5      SWOT Analysis

12.4.6      Key Developments

12.5      Eurofins Scientific

12.5.1      Key Facts

12.5.2      Business Description

12.5.3      Products and Services

12.5.4      Financial Overview

12.5.5      SWOT Analysis

12.5.6      Key Developments

12.7      Guardant Health

12.7.1      Key Facts

12.7.2      Business Description

12.7.3      Products and Services

12.7.4      Financial Overview

12.7.5      SWOT Analysis

12.7.6      Key Developments

13.          Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms


LIST OF TABLES

Table 1.              Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 3.              Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.              France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 5.              France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 6.              France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7.              UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8.              UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 9.              UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.            Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11.            Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 12.            Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13.            Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 14.            Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 15.            Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.            Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 17.            Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 18.            Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.            Recent Inorganic Growth Strategies in the Laboratory Developed Test Market

Table 20.            Recent Organic Growth Strategies in the Laboratory Developed Test Market

Table 21.            Glossary of Terms, Laboratory Developed Test Market

 


LIST OF FIGURES

Figure 1.            Laboratory Developed Test Market Segmentation

Figure 2.            Laboratory Developed Test Market Segmentation, By Country

Figure 3.            Europe Laboratory Developed Test Market Overview

Figure 4.            Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market

Figure 5.            Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)

Figure 6.            Europe and PEST Analysis

Figure 1.            Laboratory Developed Test Market Impact Analysis of Drivers and Restraints

Figure 2.            Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028

Figure 3.            Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

Figure 4.            Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 5.            Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 6.            Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 7.            Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8.            Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9.            Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

Figure 16.          Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)

Figure 22.          Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

Figure 23.          Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.          France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.          UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.          Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.          Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.          Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.          Impact of COVID-19 Pandemic in European Country Markets

 

 

  1. Quest Diagnostics Incorporated
  2. F.HOFFMANN-LA ROCHE LTD
  3. QIAGEN
  4. Illumina, Inc.
  5. Eurofins Scientific
  6. Guardant Health
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. 
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000